Cargando…

Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials

Randomised controlled trials (RCTs) evaluating the management of acute exacerbations of chronic obstructive pulmonary disease (COPD) report heterogeneous outcome measures, thus rendering their results incomparable, complicating their translation into clinical practice. As a first step in the develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathioudakis, Alexander G., Moberg, Mia, Janner, Julie, Alonso-Coello, Pablo, Vestbo, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513037/ https://www.ncbi.nlm.nih.gov/pubmed/31111041 http://dx.doi.org/10.1183/23120541.00072-2019

Ejemplares similares

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis
por: Jabarkhil, Ajmal, et al.
Publicado: (2020)

Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study
por: Mathioudakis, Alexander G., et al.
Publicado: (2021)

Prevention of COPD exacerbations: medications and other controversies
por: Vestbo, Jørgen, et al.
Publicado: (2015)

COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
por: Higham, Andrew, et al.
Publicado: (2020)

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
por: Sivapalan, Pradeesh, et al.
Publicado: (2017)

Was the implementation strategy of the ProACT trial adequately proactive?
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol
por: Kefala, Anastasia M, et al.
Publicado: (2020)

Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population
por: Kamstrup, Peter, et al.
Publicado: (2022)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study
por: Reilev, Mette, et al.
Publicado: (2017)

Automated oxygen control with O2matic(®) during admission with exacerbation of COPD
por: Hansen, Ejvind Frausing, et al.
Publicado: (2018)

Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease
por: Moberg, Mia, et al.
Publicado: (2014)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD
por: Vestbo, Jørgen, et al.
Publicado: (2022)

COVID-19 Clinical Trials: Unraveling a Methodological Gordian Knot
por: Mathioudakis, Alexander G., et al.
Publicado: (2020)

β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
por: Chang, Catherina L., et al.
Publicado: (2017)

Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review
por: Mathioudakis, Alexander G., et al.
Publicado: (2020)

Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2021)

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019)

Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
por: Kjærgaard, Jakob L., et al.
Publicado: (2020)

Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
por: Langholm, Lasse L, et al.
Publicado: (2020)

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
por: Cotton, Seonaidh, et al.
Publicado: (2022)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
por: Beeh, Kai M, et al.
Publicado: (2013)

Capsule Commentary on Bremmer et. al., Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations
por: Mathioudakis, Alexander G.
Publicado: (2018)

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap
por: Ingebrigtsen, Truls Sylvan, et al.
Publicado: (2020)

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD
por: Al-shair, Khaled, et al.
Publicado: (2011)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_72gm21bl4bp9k98qt7casdpkkl